Anabios Closes Financing With Ampersand Capital Partners
06/07/22, 9:00 AM
Location
Industry
community and lifestyle
AnaBios Corporation, a leading preclinical contract research organization (CRO) that focuses on translational research with unique capabilities to measure drug activity directly in human tissue, today announced an investment from Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors.
Company Info
Location
san diego, california, united states
Additional Info
As a preclinical CRO, AnaBios has the most extensive network of hospitals and transplant centers for obtaining human tissue samples from ethically consented donors for ex vivo analysis. "AnaBios is thrilled to partner with Ampersand to elevate our business in the growing pharma industry," said Dr. Andre Ghetti, CEO of AnaBios.